Document is current
Any future updates will be listed below
-
Authors
Gratz, Johannes
Ulbing, Stefan
Schäfer, Fabian
Koch, Stefan
Dibiasi, Christoph
Wiegele, Marion
Quehenberger, Peter
Schaden, Eva
- License Information
-
More Information
Article History
Received: 8 August 2024
Accepted: 26 November 2024
First Online: 27 November 2024
Declarations
:
: JG received honoraria, research funding, and travel reimbursement from Alexion, Boehringer Ingelheim, CSL Behring, Instrumentation Laboratory, Johnson & Johnson, Mitsubishi Tanabe Pharma, Octapharma, Portola, and Takeda. SU received speaking fees from CSL Behring, Astra Zeneca, Arjo, Biomedica, Ekomed, NovoNordisk, and Roche. CD received speaking fees from CSL Behring, Astra Zeneca, Arjo, Biomedica, Ekomed, NovoNordisk, and Roche. ES received speaking fees from CSL Behring, Astra Zeneca, Arjo, Biomedica, Ekomed, NovoNordisk, Roche, B. Braun, and Bristol Myers Squibb. FS, SK, MW, and PQ declare that they have no competing interests.
: This study was approved by the Ethics Committee of the Medical University of Vienna (EK 1937/2022, 23/02/2023) and was performed in accordance with the principles of good clinical practice and the Declaration of Helsinki. Written informed consent was obtained from all the participants.
